Report cover image

Infectious Respiratory Disease Diagnostics Market

Published Jan 08, 2026
Length 120 Pages
SKU # GV20873126

Description

Infectious Respiratory Disease Diagnostics Market Summary

The global infectious respiratory disease diagnostics market size was estimated at USD 12.56 billion in 2025 and is projected to reach USD 15.70 billion by 2033, growing at a CAGR of 2.90% from 2026 to 2033. The market is being driven by several key factors, including the growing prevalence of diseases like tuberculosis and pneumonia, advancements in diagnostic technologies, and increased partnerships and collaborations between major players.

For instance, in February 2023, Thermo Fisher Scientific and Mylab Discovery Solutions announced a partnership to develop and distribute diagnostic test kits for infectious diseases such as multi-drug-resistant tuberculosis, hepatitis B virus, hepatitis C virus, HIV, and genetic analysis (HLA B27) in India. The collaboration aims to combine Thermo Fisher’s global expertise with Mylab’s local manufacturing capabilities to expand access to high-quality testing solutions.

The increasing funding for TB diagnosis programs is crucial in the fight against this global disease. The current funding for prevention, diagnosis, and treatment is insufficient to meet the demand, hindering progress in reducing incidence & mortality rates. For instance, an annual investment of USD 22 billion by 2027 was set, with an additional USD 5 billion for research, and only USD 5.8 billion was allocated for TB services, falling short of the required amounts to achieve global targets. Moreover, WHO emphasizes the need for sustained & increased funding to combat TB effectively. Hence, the U.S. government has significantly increased its funding for TB initiatives, from USD 233 million in 2013 to USD 406 million in 2023. Investments in screening and preventive treatment have shown significant health & economic benefits, with a return on investment of up to USD 39 for every dollar spent.

Global Infectious Respiratory Disease Diagnostics Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global infectious respiratory disease diagnostics market report based on technology, pathogen, end-use, and region:
  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Instruments
  • Reagents
  • Services
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • COVID-19
  • Influenza
  • Respiratory Syncytial Virus (RSV)
  • Tuberculosis
  • Non-tuberculosis Mycobacterium Testing
  • Bacterial Pneumonia Testing
  • Other Respiratory Disease Testing
  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Immunoassay
  • Molecular Diagnostics
  • Microbiology
  • Rapid/Point-of-Care Diagnostics
  • Other Technologies
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Diagnostic Laboratories
  • Clinics
  • Research Institutes
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Norway
  • Denmark
  • Sweden
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
  • Latin America
  • Brazil
  • Argentina
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
Please note The report will be delivered in 2-3 business days upon order notification.

Table of Contents

120 Pages
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Segment Definitions
1.2. Estimates and Forecast Timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased Database
1.4.2. GVR’s Internal Database
1.4.3. Secondary Sources
1.4.4. Primary Research
1.4.5. Details of Primary Research
1.4.6. Research Assumption
1.5. Information or Data Analysis
1.5.1. Data Analysis Models
1.6. Market Formulation & Data Visualization
1.7. Model Details
1.7.1. Commodity Flow Analysis
1.8. Objectives
1.8.1. Objective - 1
1.8.2. Objective - 2
1.8.3. Objective - 3
1.9. List of Secondary Sources
1.10. List of Secondary Sources
Chapter 2. Executive Summary
2.1. U.S. Hospital Facilities Market
2.1.1. Market Snapshot
2.1.2. Segment Snapshot
2.1.2.1. Patient service segment outlook
2.1.2.2. Facility type segment outlook
2.1.2.3. Service type segment outlook
2.1.2.4. Bed size segment outlook
2.1.2.5. Region outlook
2.1.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.1.1. Growing impetus for better patient car
3.3.1.2. Increasing Demand for Healthcare Services
3.3.1.3. Shift Towards Outpatient Services
3.3.1.4. Increasing Healthcare Expenditure
3.3.2. Market Restraint Analysis
3.3.2.1. Stringent Regulatory Policies
3.3.2.2. Patient Safety Concerns
3.4. Regulatory Framework
3.5. Business Environment Analysis Tools
3.5.1. Industry Analysis - Porter’s Five Forces Analysis
3.5.1.1. Supplier power
3.5.1.2. Buyer power
3.5.1.3. Substitution threat
3.5.1.4. Threat of new entrant
3.5.1.5. Competitive rivalry
3.5.2. PESTEL Analysis
Chapter 4. Patient Service Business Analysis
4.1. U.S. Hospital Facilities Market: Patient Service Movement Analysis
4.2. U.S. Hospital Facilities Market: Patient Service Segment Dashboard
4.3. Patient Service Movement & Market Share Analysis, 2025 & 2033
4.4. U.S. Hospital Facilities Market Estimates & Forecast, by Patient Service
4.5. Inpatient Services
4.5.1. Inpatient services market, 2021 - 2033 (USD Billion)
4.6. Outpatient Services
4.6.1. Outpatient services market, 2021 - 2033 (USD Billion)
Chapter 5. Facility Type Business Analysis
5.1. U.S. Hospital Facilities Market: Facility Type Movement Analysis
5.2. U.S. Hospital Facilities Market: Facility Type Segment Dashboard
5.3. Facility Type Movement & Market Share Analysis, 2025 & 2033
5.4. U.S. Hospital Facilities Market Estimates & Forecast, by Facility Type
5.5. Private Hospitals
5.5.1. Private hospitals market, 2021 - 2033 (USD Billion)
5.6. State Owned & Federal Hospitals
5.6.1. State owned & federal hospitals market, 2021 - 2033 (USD Billion)
5.7. Public/Community Hospitals
5.7.1. Public/community hospitals market, 2021 - 2033 (USD Billion)
Chapter 6. Service Type Business Analysis
6.1. U.S. Hospital Facilities Market: Service Type Movement Analysis
6.2. U.S. Hospital Facilities Market: Service Type Segment Dashboard
6.3. Service Type Movement & Market Share Analysis, 2025 & 2033
6.4. U.S. Hospital Facilities Market Estimates & Forecast, by Service Type
6.5. Acute Care
6.5.1. Acute care market, 2021 - 2033 (USD Billion)
6.6. Cardiovascular
6.6.1. Cardiovascular market, 2021 - 2033 (USD Billion)
6.7. Cancer care
6.7.1. Cancer care market, 2021 - 2033 (USD Billion)
6.8. Neurorehabilitation & Psychiatry Services
6.8.1. Neurorehabilitation & psychiatry services market, 2021 - 2033 (USD Billion)
6.9. Pathology Lab, Diagnostics, and Imaging
6.9.1. Pathology lab, diagnostics, and imaging market, 2021 - 2033 (USD Billion)
6.10. Obstetrics & Gynecology
6.10.1. Obstetrics & gynecology market, 2021 - 2033 (USD Billion)
6.11. Others
6.11.1. Others market, 2021 - 2033 (USD Billion)
Chapter 7. Bed Size Business Analysis
7.1. U.S. Hospital Facilities Market: Bed Size Movement Analysis
7.2. U.S. Hospital Facilities Market: Bed Size Segment Dashboard
7.3. Bed Size Movement & Market Share Analysis, 2025 & 2033
7.4. U.S. Hospital Facilities Market Estimates & Forecast, by Bed Size
7.5. 0-99
7.5.1. 0-99 market, 2021 - 2033 (USD Billion)
7.6. 100-199
7.6.1. 100-199 market, 2021 - 2033 (USD Billion)
7.7. 200-299
7.7.1. 200-299 market, 2021 - 2033 (USD Billion)
7.8. 300-more
7.8.1. 300-more market, 2021 - 2033 (USD Billion)
Chapter 8. Region Business Analysis
8.1. U.S. Hospital Facilities Market: Region Movement Analysis
8.2. U.S. Hospital Facilities Market: Region Segment Dashboard
8.3. Region Movement & Market Share Analysis, 2025 & 2033
8.4. U.S. Hospital Facilities Market Estimates & Forecast, by Region
8.5. Southeast
8.5.1. Southeast market, 2021 - 2033 (USD Billion)
8.6. Midwest
8.6.1. Midwest market, 2021 - 2033 (USD Billion)
8.7. West
8.7.1. West market, 2021 - 2033 (USD Billion)
8.8. Northeast
8.8.1. Northeast market, 2021 - 2033 (USD Billion)
8.9. Southwest
8.9.1. Southwest market, 2021 - 2033 (USD Billion)
Chapter 9. Competitive Landscape
9.1. Company Categorization
9.2. Company Market Position Analysis, 2025
9.3. Company Share Analysis
9.4. Strategy Mapping
9.4.1. Partnership/Collaboration/Alliance
9.4.2. New Product Launch
9.4.3. Mergers & Acquisitions
9.4.4. Others
9.5. Company Profiles/Listing
9.5.1. The Johns Hopkins Hospital
9.5.1.1. Overview
9.5.1.2. Financial performance
9.5.1.3. Service benchmarking
9.5.1.4. Strategic initiatives
9.5.2. Mayo Clinic
9.5.2.1. Overview
9.5.2.2. Financial performance
9.5.2.3. Service benchmarking
9.5.2.4. Strategic initiatives
9.5.3. Cleveland Clinic
9.5.3.1. Overview
9.5.3.2. Financial performance
9.5.3.3. Service benchmarking
9.5.3.4. Strategic initiatives
9.5.4. Cedars-Sinai
9.5.4.1. Overview
9.5.4.2. Financial performance
9.5.4.3. Service benchmarking
9.5.4.4. Strategic initiatives
9.5.5. Massachusetts General Hospital
9.5.5.1. Overview
9.5.5.2. Financial performance
9.5.5.3. Service benchmarking
9.5.5.4. Strategic initiatives
9.5.6. UCSF HEALTH
9.5.6.1. Overview
9.5.6.2. Financial performance
9.5.6.3. Service benchmarking
9.5.6.4. Strategic initiatives
9.5.7. NewYork-Presbyterian Hospital
9.5.7.1. Overview
9.5.7.2. Financial performance
9.5.7.3. Service benchmarking
9.5.7.4. Strategic initiatives
9.5.8. Brigham and Women's Hospital
9.5.8.1. Overview
9.5.8.2. Financial performance
9.5.8.3. Service benchmarking
9.5.8.4. Strategic initiatives
9.5.9. Ronald Regan UCLA Medical Center
9.5.9.1. Overview
9.5.9.2. Financial performance
9.5.9.3. Service benchmarking
9.5.9.4. Strategic initiatives
9.5.10. Northwestern Memorial Hospital
9.5.10.1. Overview
9.5.10.2. Financial performance
9.5.10.3. Service benchmarking
9.5.10.4. Strategic initiatives 
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.